Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Hun Ju Lee, MD
University of Texas MD Anderson Cancer Center
Associate Professor of Medicine in the Department of Lymphoma & Myeloma
Published Articles (1)
Frontline Treatment of Hodgkin Lymphoma in 2026: A New Standard Emerges
May 5, 2026
Expert analysis of how SWOG S1826, nivolumab-based regimens, PET-adapted therapy, and immunotherapy combinations are redefining frontline treatment for classical Hodgkin lymphoma in 2026.